Yuanlong Xie

1.0k total citations
43 papers, 760 citations indexed

About

Yuanlong Xie is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Yuanlong Xie has authored 43 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Biomedical Engineering and 9 papers in Oncology. Recurrent topics in Yuanlong Xie's work include Bone Metabolism and Diseases (6 papers), Bone Tissue Engineering Materials (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Yuanlong Xie is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Bone Tissue Engineering Materials (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Yuanlong Xie collaborates with scholars based in China, Canada and United Kingdom. Yuanlong Xie's co-authors include Lin Cai, Feifei Yan, Zhiqiang Yang, Lingfei Xiao, Minhao Wu, Zhouming Deng, Yufeng Zhang, Wenchao Sun, Shiyi Yao and Sheng Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical Pharmacology.

In The Last Decade

Yuanlong Xie

40 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanlong Xie China 17 325 253 165 154 85 43 760
Zhouming Deng China 19 330 1.0× 438 1.7× 203 1.2× 153 1.0× 138 1.6× 30 951
Dejun Yang China 20 452 1.4× 138 0.5× 223 1.4× 129 0.8× 99 1.2× 44 899
Tina P. Dale United Kingdom 12 321 1.0× 163 0.6× 262 1.6× 103 0.7× 180 2.1× 24 814
Min Nie China 16 295 0.9× 182 0.7× 101 0.6× 100 0.6× 67 0.8× 32 740
Xiuli Wang China 17 333 1.0× 222 0.9× 116 0.7× 196 1.3× 160 1.9× 49 804
Xiaofan Yin China 19 324 1.0× 249 1.0× 163 1.0× 127 0.8× 183 2.2× 45 889
Huan‐Tian Zhang China 21 481 1.5× 170 0.7× 117 0.7× 156 1.0× 99 1.2× 40 976
Kang Tian China 15 441 1.4× 196 0.8× 226 1.4× 82 0.5× 113 1.3× 42 1000
Yutong Wu China 19 507 1.6× 269 1.1× 266 1.6× 110 0.7× 87 1.0× 51 1.0k
Nuo Zhou China 16 279 0.9× 164 0.6× 95 0.6× 161 1.0× 119 1.4× 61 756

Countries citing papers authored by Yuanlong Xie

Since Specialization
Citations

This map shows the geographic impact of Yuanlong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanlong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanlong Xie more than expected).

Fields of papers citing papers by Yuanlong Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanlong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanlong Xie. The network helps show where Yuanlong Xie may publish in the future.

Co-authorship network of co-authors of Yuanlong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanlong Xie. A scholar is included among the top collaborators of Yuanlong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanlong Xie. Yuanlong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuyang, et al.. (2025). Efficacy and safety of regorafenib in the treatment of bone sarcomas: systematic review and meta-analysis. BMC Cancer. 25(1). 302–302. 2 indexed citations
2.
Wang, Yan, Jingli Hou, Yuyang Wang, et al.. (2025). Upregulation of FAM129B protects against glucocorticoid-induced skeletal muscle atrophy via regulating long non-coding RNA NEAT1. International Journal of Biological Macromolecules. 300. 140120–140120. 2 indexed citations
3.
Zhang, Sheng, Zhiqiang Yang, Yuanlong Xie, et al.. (2025). Identification of NIBAN2‐Regulated RUNX2 Alternative Splicing Presents Novel Strategies for Antagonizing Osteoporosis. Advanced Science. 12(17). e2416536–e2416536. 2 indexed citations
4.
Yuan, Yuncong, Xiang Leng, Xiaoyu Xu, et al.. (2024). Complexity made easy: Aggregation‐induced emission small molecules for cancer diagnosis and phototherapies. SHILAP Revista de lepidopterología. 5(6). 31 indexed citations
5.
Xiao, Lingfei, Huifan Liu, Yuanlong Xie, et al.. (2024). Fishnet-Inspired 3D Scaffold Fabricated from Mesh-like Electrospun Membranes Promoted Osteoporotic Bone Regeneration. Advanced Fiber Materials. 7(1). 72–92. 26 indexed citations
6.
Yang, Min, Renxiong Wei, Sheng Zhang, et al.. (2023). NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m5C methylation. Cell Death and Disease. 14(2). 125–125. 53 indexed citations
7.
Zhu, Yufan, Yuanlong Xie, Ling Zhou, et al.. (2023). A Cu@ZIF-8 encapsulated antibacterial and angiogenic microneedle array for promoting wound healing. Nanoscale Advances. 5(18). 5102–5114. 18 indexed citations
8.
Yang, Min, Zhiqiang Yang, Lin Cai, et al.. (2023). Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation. Experimental and Therapeutic Medicine. 26(3). 457–457. 10 indexed citations
9.
Yang, Zhiqiang, et al.. (2022). Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma. Biochemical Pharmacology. 198. 114938–114938. 9 indexed citations
10.
Zhou, Ling, Yuanlong Xie, Yufan Zhu, et al.. (2022). Mesh-like electrospun membrane loaded with atorvastatin facilitates cutaneous wound healing by promoting the paracrine function of mesenchymal stem cells. Stem Cell Research & Therapy. 13(1). 190–190. 18 indexed citations
11.
Zhu, Yufan, Zhiqiang Yang, Yuanlong Xie, et al.. (2021). Investigation of inhibition effect of daidzein on osteosarcoma cells based on experimental validation and systematic pharmacology analysis. PeerJ. 9. e12072–e12072. 5 indexed citations
12.
Zhang, Yufeng, Sheng Zhang, Zhiqiang Yang, et al.. (2021). ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk‐JNK through DOK3. Oxidative Medicine and Cellular Longevity. 2021(1). 2896674–2896674. 10 indexed citations
13.
Yang, Zhiqiang, Lingfei Xiao, Zhouming Deng, Lin Cai, & Yuanlong Xie. (2021). Evaluation of Demineralized Bone Matrix Particles Delivered by Alginate Hydrogel for a Bone Graft Substitute: An Animal Experimental Study. Medical Science Monitor. 27. 3 indexed citations
14.
Xiao, Lingfei, Minhao Wu, Feifei Yan, et al.. (2021). A radial 3D polycaprolactone nanofiber scaffold modified by biomineralization and silk fibroin coating promote bone regeneration in vivo. International Journal of Biological Macromolecules. 172. 19–29. 59 indexed citations
15.
Zhang, Yufeng, et al.. (2021). The effect of miR-539 regulating TRIAP1 on the apoptosis, proliferation, migration and invasion of osteosarcoma cells. Cancer Cell International. 21(1). 227–227. 14 indexed citations
16.
Hu, Chao, Xiaobin Zhu, Zhouming Deng, et al.. (2021). Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism. Evidence-based Complementary and Alternative Medicine. 2021. 1–15. 5 indexed citations
17.
Wu, Minhao, Ping Wu, Lingfei Xiao, et al.. (2020). Biomimetic mineralization of novel hydroxyethyl cellulose/soy protein isolate scaffolds promote bone regeneration in vitro and in vivo. International Journal of Biological Macromolecules. 162. 1627–1641. 66 indexed citations
18.
Xie, Yuanlong, et al.. (2019). <p>Icariin-loaded porous scaffolds for bone regeneration through the regulation of the coupling process of osteogenesis and osteoclastic activity</p>. International Journal of Nanomedicine. Volume 14. 6019–6033. 46 indexed citations
19.
Wu, Minhao, Shiyi Yao, Yuanlong Xie, et al.. (2018). A novel subchondral bone-grafting procedure for the treatment of giant-cell tumor around the knee. Medicine. 97(45). e13154–e13154. 21 indexed citations
20.
Xie, Yuanlong, Wenchao Sun, Zhouming Deng, et al.. (2017). MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2. Scientific Reports. 7(1). 13388–13388. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhouming Deng Breakdown of academic impact, for papers by Dejun Yang Breakdown of academic impact, for papers by Tina P. Dale Breakdown of academic impact, for papers by Min Nie Breakdown of academic impact, for papers by Xiuli Wang Breakdown of academic impact, for papers by Xiaofan Yin Breakdown of academic impact, for papers by Huan‐Tian Zhang Breakdown of academic impact, for papers by Kang Tian Breakdown of academic impact, for papers by Yutong Wu Breakdown of academic impact, for papers by Nuo Zhou
Rankless by CCL
2026